Modulating inflammation through the neutralization of Interleukin-6 and tumor necrosis factor-α by biofunctionalized nanoparticles

Ana Cláudia Lima; Diana Amorim; Inês Martins Laranjeira; Armando Almeida; Rui L Reis; Helena Ferreira; Filipa Pinto‐Ribeiro; Nuno M. Neves

doi:10.1016/j.jconrel.2021.02.001

Related publications

Article2014

C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression

Patricia Chocano-Bedoya, Fariba Mirzaei, Éilis J. O’Reilly, Michel Lucas, Olivia I. Okereke, Frank B Hu, Eric B. Rimm, Alberto Ascherio

Article2000

Prognostic Value of Cytokine Concentrations (Tumor Necrosis Factor–α, Interleukin‐6, and Interleukin‐10) and Clinical Parameters in Severe Melioidosis

Andrew J. H. Simpson, Michael D. Smith, Gerrit Jan Weverling, Yupin Suputtamongkol, Brian Angus, Wipada Chaowagul, Sir Nicholas White, Sander J. H. van Deventer, Jan M. Prins

The Journal of Infectious Diseases

Article2005

Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor α and interleukin-6

Marta Kubera, Michael Maes, Günter Kenis, Yong‐Ku Kim, Władysław Lasoń

Article2006

Differential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of Cholestasis

Andrew J. Lickteig, Angela L. Slitt, Melek C. Arkan, Michael Karin, Nathan J. Cherrington

Article2020

Biofunctionalized Liposomes to Monitor Rheumatoid Arthritis Regression Stimulated by Interleukin‐23 Neutralization

Ana Cláudia Lima, Cláudia F. Campos, Cristina Cunha, Agostinho Carvalho, Rui L Reis, Helena Ferreira, Nuno M. Neves